Guo Guangchang looks back on Fosun's 30 years and reveals the future development direction of Fosun
Retrieved on:
Monday, December 19, 2022
Market analysts believe that Fosun is actively making strategic focus in the face of the constant changes in the macro environment.
Key Points:
- Market analysts believe that Fosun is actively making strategic focus in the face of the constant changes in the macro environment.
- On 15 December, Fosun held the Fosun's 30th Anniversary ONE FOSUN Family Members' Carnival.
- In Guo Guangchang's speech on 15 December, he shared the moment of the successful acquisition of Club Med in 2015.
- Guo Guangchang said, "BioNTech, a Germany biotechnology company, chose to cooperate with Fosun to develop the COVID-19 mRNA vaccine because they recognize Fosun Pharma's research and development capabilities and globalization strategy.